Lawrence Leichman at [NYU Langone Medical Center]

Lawrence P. Leichman, MD

  • Specialty: Medical Oncology
  • Language: English
  • Phone: 212-731-5770

About Me

Conditions and Treatments

liver cancer, gastrointestinal cancer, stomach cancer, pancreatic cancer, colon cancer, gallbladder cancer, esophageal cancer, rectal cancer


  • Professor, Department of Medicine
  • Dir Sec of GI Malignancies Div of Hematology & Onc
Board Certifications
  • American Board of Internal Medicine (Medical Oncology), 1983
  • American Board of Internal Medicine - Internal Medicine, 1977
Education and Training
  • Fellowship, Wayne State University, Medical Oncology, 1979
  • MD from Wayne State University, 1973

Locations and Appointments

75 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Agewell
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP Essential
  • HIP Family Health
  • HIP Medicaid
  • HIP Medicare
  • HealthSmart (WTC)
  • Healthfirst
  • Healthfirst Essential
  • Humana Medicare
  • Independent Care System New York
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • PHP
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
  • Wellcare Exchange
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Medical Oncology Associates

160 East 34th Street
New York, NY 10016


Phone: 212-731-5770

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Research in Clinical Trials in Gastrointestinal Malignancies testing. The molecular profiles of these cancers to determine the best treatment.


  • Methylation profiling of locally advanced rectal cancer (LARC): Exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). [Meeting Abstract]

    Guo, Songchuan; Melamed, Jonathan; Eze, Ogechukwu; Bowman, Christopher; Ahmed, Sunjida; Moore, Harvey G; Loomis, Cynthia; Heguy, Adriana; Brody, Rachel; Morrison, Debra J; Serrano, Jonathan; Du, Kevin Lee; Wu, Jennifer J; Ryan, Theresa; Cohen, Deirdre Jill; Gu, Ping; Goldberg, Judith D; Snuderl, Matija; Leichman, Lawrence P; Leichman, Cynthia G
    Journal of clinical oncology. 2016 FEB 1. 34 (4): ?-?

  • Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer

    Leichman, Lawrence; Groshen, Susan; O'Neil, Bert H; Messersmith, Wells; Berlin, Jordan; Chan, Emily; Leichman, Cynthia G; Cohen, Steven J; Cohen, Deirdre; Lenz, Heinz-Josef; Gold, Philip; Boman, Bruce; Fielding, Anitra; Locker, Gershon; Cason, Ronald C; Hamilton, Stan R; Hochster, Howard S
    Oncologist. 2016 Jan 19. 21 (2): 172-177

  • Antitumor activity and immune reponse in CD40 immunotherapy with gemcitabine and nab-paclitaxel in an orthotopic pancreatic cancer mouse model [Meeting Abstract]

    Siolas, D; Cullis, J; Avanzi, A; Byrne, K; Leichman, L P; Vonderheide, R H; Bar-Sagi, D
    Journal of clinical oncology. 2016 01 Feb 2016. 34 (4):

Read All Publications (63)